Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
Andreas M Pleil,1 Feyza Darendeliler,2 Helmuth G Dörr,3 Katherine Hutchinson,4 Hartmut A Wollmann5 1Pfizer Inc., San Diego, CA, USA; 2Istanbul Faculty of Medicine, Pediatric Endocrinology Unit, Capa, Istanbul, Turkey; 3Department of Pediatrics, University of Erlangen, Erlangen, Germany; 4Q...
Main Authors: | Pleil AM, Darendeliler F, Dörr HG, Hutchinson K, Wollmann HA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-04-01
|
Series: | Medical Devices : Evidence and Research |
Online Access: | http://www.dovepress.com/results-from-an-international-multicenter-trial-evaluating-the-ease-of-a16461 |
Similar Items
-
Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
by: Pleil Andreas M, et al.
Published: (2012-10-01) -
Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
by: Lee JE, et al.
Published: (2019-12-01) -
Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease
by: Ricanek P, et al.
Published: (2012-09-01) -
Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data
by: Mannino DM, et al.
Published: (2018-05-01) -
Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
by: Illingworth PJ, et al.
Published: (2014-06-01)